M

Moderna

Develops mRNA-based medicines for health

Associate Director - CMC Regulatory Science

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeNo salary listed

About the Job

Requirements

  • A BS, MS, or PhD in Molecular Biology, Pharmaceutics, Chemistry, Chemical Engineering, or a closely related field is required.
  • At least 8 years of experience in the pharmaceutical or biotechnology industry, with manufacturing and/or analytical focus.
  • At least 5 years of experience in biologics-focused Regulatory CMC.
  • Strong knowledge of current UK CMC regulations, including the format and content of CMC regulatory submissions in Common Technical Document format.
  • Knowledge of and broad experience with regulatory procedures and legislation related to CMC aspects of drug development, product registration, and post-approval lifecycle management.

Responsibilities

  • Define, execute, and continuously refine comprehensive CMC regulatory strategies for assigned UK-manufactured and UK-licensed products across development, registration, commercialisation, and post-approval lifecycle activities.
  • Provide regulatory leadership and oversight for CMC and Quality-related regulatory submissions, ensuring scientific robustness, strategic alignment, technical accuracy, submission readiness, and alignment with MHRA requirements and Common Technical Document expectations.
  • Assess proposed manufacturing process, analytical, and other quality-related changes; determine regulatory filing implications, evaluate risks and mitigation options, and recommend appropriate regulatory pathways.
  • Serve as a primary contact for CMC regulatory matters with the Medicines and Healthcare products Regulatory Agency and engage with other international health authorities; lead or participate in meetings, scientific discussions, and agency interactions.
  • Monitor, interpret, and communicate UK CMC regulations, MHRA guidance, regulatory policy, and international requirements, translating changes into programme-level strategies, internal standards, submission approaches, and best practices.
  • Establish and strengthen CMC compliance frameworks; identify regulatory challenges and compliance gaps, develop risk-mitigation strategies, and make risk-based decisions in complex or ambiguous situations.
  • Provide strategic direction across matrix teams, align stakeholders on regulatory objectives and submission priorities, facilitate cross-functional decisions, and coordinate responses to regulatory questions and compliance challenges.
  • Contribute to international CMC regulatory strategies, integrate UK considerations into global development and commercialisation plans, and address differences between national requirements for international submissions and lifecycle activities.
  • Develop and improve regulatory CMC processes, procedures, submission templates, standardised frameworks, and working practices to improve consistency, technical quality, and efficiency.
  • Identify appropriate digital solutions, including Generative AI tools, to support regulatory intelligence, submission planning, knowledge management, CMC documentation, guidance interpretation, document preparation, and process efficiency while maintaining scientific oversight, data integrity, confidentiality, and compliance.
  • Present regulatory issues, scientific considerations, risks, options, and recommendations to senior stakeholders and governance forums, and influence strategic decisions.
  • Evaluate technically challenging regulatory situations, develop risk-based recommendations, and drive decisions that protect compliance while enabling programme progression and alignment with global strategies.
  • Provide technical leadership, coaching, and mentorship to junior regulatory professionals in biologics CMC, submissions, agency interactions, and lifecycle management.
  • Build relationships and promote collaborative problem-solving with technical experts, programme leaders, and senior stakeholders across the organisation.
  • Contribute to improving regulatory practices and capabilities and support development and commercialisation of mRNA medicines.

Desired Qualifications

  • Knowledge of current CMC regulations outside the UK.
  • Ability to lead and influence in a dynamic, cross-functional matrix environment to achieve strategic alignment and regulatory milestones.
  • Ability to work independently, exercise sound judgment, and make risk-based regulatory recommendations in complex or ambiguous situations.
  • Strong written and oral communication skills, including clearly framing regulatory risks, options, recommendations, and trade-offs for senior stakeholders.
  • Experience defining and leading global CMC regulatory strategy for complex development or lifecycle programmes.
  • Ability to lead without direct authority and drive alignment across Technical Development, Manufacturing, Quality, Clinical, Commercial, and Regulatory stakeholders.
  • Experience contributing to CMC regulatory policy interpretation, process improvement, submission standards, or functional best practices.
  • Ability to represent CMC regulatory strategy in internal governance forums and, where appropriate, interactions with health authorities.

About the Company

Moderna

Develops mRNA-based medicines for health

Moderna develops medicines built on messenger RNA (mRNA). Its products use mRNA delivered into cells to instruct them to produce specific proteins that can prevent or treat disease, with vaccines being a primary example. In practice, a dose delivers engineered mRNA into the body, cells translate it into a target protein, and the immune system responds or the protein modulates biology to combat disease. Moderna differentiates itself through its focus on building a whole mRNA medicines platform and in-house capabilities for designing, manufacturing, and scaling mRNA therapies, including rapid development and large-scale production. Its goal is to create a new category of medicines based on mRNA that can improve how diseases are discovered, developed, and treated, ultimately improving patient outcomes.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2010

Recently Posted Jobs

Explore more opportunities at Moderna

See more jobs